Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Spiera

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Rheumatic Diseases Clinics of North America|March 1, 2006
Newer therapeutic approaches to the vasculitides: biologic agentsJonathan Samuels, Robert Spiera
Annals of the Rheumatic Diseases|March 6, 2012
Provisional diagnostic criteria for polymyalgia rheumatica: moving beyond clinical intuition?Robert Spiera, Rene Westhovens
Arthritis and Rheumatism|March 6, 2012
Provisional classification [corrected] criteria for polymyalgia rheumatica: moving beyond clinical intuition?Robert Spiera, René Westhovens
The Journal of Rheumatology|December 15, 2022
B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With RituximabKaitlin Schultz, Deanna Jannat-Khah, Robert Spiera
Annals of the Rheumatic Diseases|May 12, 2021
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseasesRobert Spiera, Sarah Jinich, Deanna Jannat-Khah
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia RheumaticaLindsay Lally, Lindsy Forbess, Christopher Hatzis, et al.
Rheumatology Advances in Practice|May 7, 2026
Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologistsGenna Braverman, Kerri I Aronson, Charlene Thomas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 15, 2021
B Cell Reconstitution Is Strongly Associated With COVID-19 Vaccine Responsiveness in Rheumatic Disease Patients Who Received Treatment With RituximabSarah Jinich, Kaitlin Schultz, Deanna Jannat-Khah, et al.
Rheumatology (Oxford, England)|September 13, 2014
Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritisLindsay Lally, Alessandra Pernis, Navneet Narula, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Response to: 'Correspondence on 'Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement'' by ManettiKimberly Showalter, Cynthia Magro, Yaxia Zhang, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Rheumatic Diseases Clinics of North America|March 1, 2006
Newer therapeutic approaches to the vasculitides: biologic agentsJonathan Samuels, Robert Spiera
Annals of the Rheumatic Diseases|March 6, 2012
Provisional diagnostic criteria for polymyalgia rheumatica: moving beyond clinical intuition?Robert Spiera, Rene Westhovens
Arthritis and Rheumatism|March 6, 2012
Provisional classification [corrected] criteria for polymyalgia rheumatica: moving beyond clinical intuition?Robert Spiera, René Westhovens
The Journal of Rheumatology|December 15, 2022
B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With RituximabKaitlin Schultz, Deanna Jannat-Khah, Robert Spiera
Annals of the Rheumatic Diseases|May 12, 2021
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseasesRobert Spiera, Sarah Jinich, Deanna Jannat-Khah
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia RheumaticaLindsay Lally, Lindsy Forbess, Christopher Hatzis, et al.
Rheumatology Advances in Practice|May 7, 2026
Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologistsGenna Braverman, Kerri I Aronson, Charlene Thomas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 15, 2021
B Cell Reconstitution Is Strongly Associated With COVID-19 Vaccine Responsiveness in Rheumatic Disease Patients Who Received Treatment With RituximabSarah Jinich, Kaitlin Schultz, Deanna Jannat-Khah, et al.
Rheumatology (Oxford, England)|September 13, 2014
Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritisLindsay Lally, Alessandra Pernis, Navneet Narula, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Response to: 'Correspondence on 'Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement'' by ManettiKimberly Showalter, Cynthia Magro, Yaxia Zhang, et al.
Pageof 10